• The regulatory response in non-allergic people and those with severe peanut allergy (K. Hayglass, E. Simons)
• Is the prevalence of peanut allergy increasing? A five-year follow-up study on the prevalence of peanut allergy in Montreal school children aged 5 to 9 years (A. Clarke)
• Impact of PAF receptor blockade in murine peanut-induced anaphylaxis (M. Jordana)
• Evaluation of the implementation and effectiveness of statutory and regulatory school-based policies for anaphylaxis-risk reduction (L. Cicutto)
• McMaster peanut allergy research initiative* (M. Jordana, S. Waserman)
  *Funded through contributions from the Sean Delaney Memorial Classic Golf Tournament
  

In-kind support

Though we cannot always give a cash donation, we have been able to support many investigators in a meaningful way through our in-kind contributions.

Anaphylaxis Canada, considered a "key opinion leader" in the community, is able to provide the perspective of the patient / consumer. This has helped researchers better understand the challenges faced by those living with potentially life-threatening allergies.

We have given valuable input on surveys as well as made presentations at research and medical conferences. Through our Canadian Anaphylaxis Registry, we have connected thousands of research participants with investigators in North America.

Published Studies

Anaphylaxis Canada has participated in the following research studies as a co-investigator or supported the research with funding*.

A Study of 32 Food-Induced Anaphylaxis Deaths in Ontario; 1986-2000* Salter J, Mehra S, Cairns JT, Sussman G, Vadas P (unpublished study; poster presentation at AAAAI conference, 2001)

Impact of CD40 ligand, B cells, and mast cells in peanut-induced anaphylactic responses* Sun J, Arias K, Alvarez D, Fattouh R, Walker T, Goncharova S, Kim B, Waserman S, Reed J, Coyle AJ, Jordana M. J Immunol. 2007 Nov 15;179(10):6696-703

Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions* Arias K, Baig M, Colangelo M, Chu D, Walker T, Goncharova S, Coyle A, Vadas P, Waserman S, Jordana M. Allergy Clin Immunol. 2009 Aug;124(2):307-14, 314.e1-2

Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal* Ben-Shoshan M, Kagan RS, Alizadehfar R, Joseph L, Turnbull E, St Pierre Y, Clarke AE. J Allergy Clin Immunol. 2009 Apr;123(4):783-8

Management of Food-induced Anaphylaxis: Unsolved Challenges* M Jordana, S Waserman, K Arias; Current Clinical Pharmacology, 2009 Vol 4, No 2

Illustrating risk: anaphylaxis through the eyes of the food-allergic child Fenton NE, Elliott SJ, Cicutto L, Clarke AE, Harada L, McPhee E. Risk Anal. 2011 Jan;31(1):171-83

Role of food labels in accidental exposures in food-allergic individuals in Canada Sheth SS, Waserman S, Kagan R, Alizadehfar R, Primeau MN, Elliot S, St Pierre Y, Wickett R, Joseph L, Harada L, Dufresne C, Allen M, Allen M, Godefroy SB, Clarke AE. Ann Allergy Asthma Immunol. 2010 Jan;104(1):60-5

Gaps in anaphylaxis management at the level of physicians, patients, and the community: a systematic review of the literature M. Kastner, L. Harada, Waserman S. Allergy Apr;65(4):435-44, 2010

Establishing the diagnosis of peanut allergy in children never exposed to peanut or with an uncertain history: a cross-Canada study Ben-Shoshan M, Kagan R, Primeau MN, Alizadehfar R, Turnbull E, Harada L, Dufresne C, Allen M, Joseph L, St Pierre Y, Clarke A. Pediatr Allergy Immunol. 2010 Sep;21(6):920-6